Sun Pharma gets US nod for women’s drugSeptember 12th, 2008 - 9:44 pm ICT by IANS
New Delhi, Sep 12 (IANS) Drug manufacturer Sun Pharmaceuticals Friday said it had received final approval from the US Food and Drug Administration to manufacture and sell generic alendronate sodium tablets for treatment of osteoporosis among women.Alendronate sodium tablets are the generic version of pharma major Merck’s Fosamax tablets, which are administered for the treatment and prevention of osteoporosis among post-menopausal women.
The approval is for doses of five mg, 10 mg, 35 mg and 70 mg, the company said.
In a regulatory statement, Sun said Fosamax tablets have annual sales of about $560 million in the US.
The company said these products will hit the market shortly.